市場調查報告書
商品編碼
1467871
2024-2032 年按產品、准入、程序、最終用戶和地區分類的血管閉合裝置市場報告Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2024-2032 |
IMARC Group年,全球血管閉合裝置市場規模達15億美元。蓬勃發展的醫療保健產業、心血管疾病盛行率的增加以及患者對有效失血管理的需求不斷成長是推動市場的一些關鍵因素。
血管閉合裝置 (VCD) 在全球各地的醫院、診所以及專科和門診手術中心使用,用於在血管造影後立即密封動脈中的小穿孔。與傳統的機械壓迫相比,這些裝置廣泛用於透過股骨途徑接受導管插入術的患者。它們有助於降低腹股溝穿刺部位立即出血的風險。除此之外,它們還有助於建立良好的身體習慣以及抗凝血和抗血小板治療。由於它們具有多種優勢,例如縮短止血時間、促進患者活動、減輕患者因長期臥床而引起的不適、減少住院時間以及預防股動脈併發症,因此全球範圍內對 VCD 的需求正在不斷增加。
目前,全球中風、冠狀動脈心臟病、週邊動脈疾病和主動脈疾病等心血管疾病(CVD)的盛行率呈上升趨勢。這與蓬勃發展的醫療保健產業一起,是支持市場成長的關鍵因素之一。除此之外,對診斷和治療心血管疾病的導管插入術和介入手術的需求不斷成長,為行業投資者提供了利潤豐厚的成長機會。此外,醫院和手術中心對先進手術設備的需求不斷成長,對市場產生了積極影響。此外,世界各地在冠狀動脈造影和其他介入手術期間對股骨模式血管通路的需求不斷增加。再加上對避免縫合和疤痕的非侵入性手術的需求不斷成長,正在對市場產生積極影響。除此之外,醫生對外科手術期間患者有效失血管理的日益關注正在加強市場的成長。此外,該行業的主要製造商正專注於製造大口徑血管閉合裝置。與此一致的是,主要市場參與者的創新設備註冊數量不斷增加正在推動市場的成長。此外,大眾對 VCD 好處的認知不斷提高,例如微創、患者治療效果好、早期下床活動以及手術過程中的舒適度,這些都促進了市場的成長。
The global vascular closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The burgeoning healthcare industry, increasing prevalence of cardiovascular diseases, and the rising demand for effective blood loss management in patients represent some of the key factors driving the market.
Vascular closure devices (VCDs) are used in hospitals, clinics, and specialty and ambulatory surgery centers across the globe to immediately seal the small puncture made in an artery after an angiogram. These devices are widely utilized among patients undergoing catheterization via the femoral route as compared to traditional mechanical compression. They assist in reducing the risk of immediate bleeding from the groin puncture site. Besides this, they also aid in setting a large body habitus and anticoagulation and antiplatelet therapies. As they offer various benefits, such as reducing the time to hemostasis, facilitating patient mobilization, lowering patient discomfort associated with prolonged bed rest, decreasing hospital stays, and preventing femoral artery complications, the demand for VCDs is increasing worldwide.
At present, there is a rise in the prevalence of cardiovascular diseases (CVDs), such as stroke and coronary heart, peripheral arterial, and aortic diseases, across the globe. This, along with the burgeoning healthcare industry, represents one of the key factors supporting the growth of the market. Besides this, the escalating demand for catheterization and interventional procedures for diagnosing and treating CVDs is offering lucrative growth opportunities to industry investors. In addition, the growing demand for advanced surgical equipment in hospitals and surgical centers is positively influencing the market. Moreover, there is an increase in the demand for femoral mode for vascular access during coronary angiography and other interventional procedures around the world. This, coupled with the growing demand for non-invasive procedures to avoid stitches and scarring, is positively influencing the market. Apart from this, the rising focus of doctors on effective blood loss management in patients during surgical procedures is strengthening the growth of the market. Additionally, key manufacturers operating in the industry are focusing on manufacturing large-bore vascular closure devices. In line with this, the increasing number of registrations for innovative devices by key market players is propelling the growth of the market. Furthermore, the rising awareness among the masses about the benefits of VCDs, such as enabling minimal invasions, high patient outcomes, early ambulation, and comfort during procedures, is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each segment of the global vascular closure devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, access, procedure, and end-user.
Passive Approximators
Collagen Plugs
Sealant or Gel-Based Devices
Compression-Assist Devices
Active Approximators
Suture-Based Devices
Clip-Based Devices
External Hemostatic Devices
The report has provided a detailed breakup and analysis of the vascular closure devices market based on the product. This includes passive approximators (collagen plugs, sealant or gel-based devices, and compression-assist devices), active approximators (suture-based devices and clip-based devices) and external hemostatic devices. According to the report, passive approximators represented the largest segment.
Femoral Access
Radial Access
A detailed breakup and analysis of the vascular closure devices market based on access has also been provided in the report. This includes femoral and radial access. According to the report, femoral access accounted for the largest market share.
Interventional Cardiology
Interventional Radiology/Vascular Surgery
A detailed breakup and analysis of the vascular closure devices market based on procedure has also been provided in the report. This includes the interventional cardiology and interventional radiology/vascular surgery. According to the report, interventional cardiology accounted for the largest market share.
Hospitals
Ambulatory Surgical Centers
Others
A detailed breakup and analysis of the vascular closure devices market based on end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for vascular closure devices. Some of factors driving the North America vascular closure devices market included the growing prevalence of cardiovascular diseases, rising trend of one-day surgeries for vascular procedures, increasing clinical trials for vascular devices, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global vascular closure devices market. Detailed profiles of all major companies have also been provided. Some of the companies include Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, Vasorum Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.